MX12317A - Derivados de ester nitrico y procedimiento para suobtencion. - Google Patents

Derivados de ester nitrico y procedimiento para suobtencion.

Info

Publication number
MX12317A
MX12317A MX1231788A MX1231788A MX12317A MX 12317 A MX12317 A MX 12317A MX 1231788 A MX1231788 A MX 1231788A MX 1231788 A MX1231788 A MX 1231788A MX 12317 A MX12317 A MX 12317A
Authority
MX
Mexico
Prior art keywords
alkyl
alkylene
suitable substituent
subset
derivatives
Prior art date
Application number
MX1231788A
Other languages
English (en)
Spanish (es)
Inventor
Youichi Shiokawa
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of MX12317A publication Critical patent/MX12317A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MX1231788A 1987-07-20 1988-07-18 Derivados de ester nitrico y procedimiento para suobtencion. MX12317A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878717068A GB8717068D0 (en) 1987-07-20 1987-07-20 Nitric ester derivative

Publications (1)

Publication Number Publication Date
MX12317A true MX12317A (es) 1993-09-01

Family

ID=10620954

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1231788A MX12317A (es) 1987-07-20 1988-07-18 Derivados de ester nitrico y procedimiento para suobtencion.

Country Status (19)

Country Link
US (2) US4923886A (enExample)
EP (1) EP0300400B1 (enExample)
JP (1) JPH0228167A (enExample)
KR (1) KR890002067A (enExample)
CN (1) CN1021046C (enExample)
AT (1) ATE102928T1 (enExample)
AU (1) AU623858B2 (enExample)
DE (1) DE3888415T2 (enExample)
DK (1) DK375988A (enExample)
FI (1) FI883402L (enExample)
GB (1) GB8717068D0 (enExample)
HU (1) HU203227B (enExample)
IL (1) IL86959A (enExample)
MX (1) MX12317A (enExample)
NO (1) NO172049C (enExample)
PH (1) PH24481A (enExample)
PT (1) PT88019B (enExample)
SU (2) SU1706388A3 (enExample)
ZA (1) ZA884987B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3941438A1 (de) * 1989-12-15 1991-06-20 Hoechst Ag Neue 2-substituierte 4-(3-alkyl-5-tert.-butyl-4-hydroxy-phenyl)-thiazole, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
IT1243367B (it) * 1990-07-26 1994-06-10 Italfarmaco Spa Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
US5298516A (en) * 1991-03-27 1994-03-29 Sankyo Company, Limited Thiazolidone compounds and method of using the same as a vasodilator
JP3454531B2 (ja) * 1991-11-07 2003-10-06 三共株式会社 ニトロキシアルキルアミド誘導体
IT1256450B (it) * 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
ES2161916T3 (es) * 1994-12-15 2001-12-16 Sankyo Co Derivados de la tiazolidinona o de la oxazolidinona para el tratamiento de la angina de pecho y composiciones que las contienen como ingrediente activo.
US5925658A (en) * 1995-03-02 1999-07-20 Sankyo Company, Limited Optically active thiazolidinone derivative
WO1996026931A1 (en) * 1995-03-02 1996-09-06 Sankyo Company, Limited Optically active thiazolidinone derivatives
IL120531A (en) 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them
EP2308833A3 (en) 1999-04-15 2011-09-28 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
JP4216193B2 (ja) * 2001-11-27 2009-01-28 エフ.ホフマン−ラ ロシュ アーゲー ベンゾチアゾール誘導体
US6624163B2 (en) * 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
US6933308B2 (en) * 2002-12-20 2005-08-23 Bristol-Myers Squibb Company Aminoalkyl thiazole derivatives as KCNQ modulators
US7273866B2 (en) * 2002-12-20 2007-09-25 Bristol-Myers Squibb Company 2-aryl thiazole derivatives as KCNQ modulators
US7968575B2 (en) * 2004-05-05 2011-06-28 Renopharm Ltd. Nitric oxide donors and uses thereof
WO2005105765A1 (en) * 2004-05-05 2005-11-10 Renopharm Ltd. Nitric oxide donors and uses thereof
US8134010B2 (en) * 2004-05-05 2012-03-13 Renopharm Ltd. Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof
DE102009037555A1 (de) * 2009-08-13 2011-03-03 Synovo Gmbh Ein neuartiges, schonendes Verfahren zur direkten Nitrierung von Hydroxyl-, Thiol- und Aminogruppen in organischen Molekülen mittels in situ generiertem Kohlensäuredinitrat
KR101045041B1 (ko) * 2009-10-27 2011-06-28 (주)에스엠이엔지 봉합침 제조방법
CA2839390C (en) * 2011-10-24 2015-09-15 Nicox S.A. Quinone based nitric oxide donating compounds
AU2013304942A1 (en) * 2012-08-23 2015-03-05 Cardiolynx Ag Extended release compositions of an aminoalkyl nitrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3433383A1 (de) * 1984-09-12 1986-03-20 Boehringer Mannheim Gmbh, 6800 Mannheim Neue phenyl-acetonitril-derivate

Also Published As

Publication number Publication date
NO883208D0 (no) 1988-07-19
DE3888415D1 (de) 1994-04-21
PT88019B (pt) 1995-03-01
US5010093A (en) 1991-04-23
PT88019A (pt) 1989-06-30
JPH0228167A (ja) 1990-01-30
EP0300400B1 (en) 1994-03-16
FI883402A0 (fi) 1988-07-18
NO172049B (no) 1993-02-22
KR890002067A (ko) 1989-04-07
NO883208L (no) 1989-01-23
IL86959A0 (en) 1988-12-30
HU203227B (en) 1991-06-28
NO172049C (no) 1993-06-02
ZA884987B (en) 1989-05-30
GB8717068D0 (en) 1987-08-26
AU623858B2 (en) 1992-05-28
AU1919988A (en) 1989-01-27
US4923886A (en) 1990-05-08
DK375988A (da) 1989-01-21
DK375988D0 (da) 1988-07-06
PH24481A (en) 1990-07-18
CN1031226A (zh) 1989-02-22
SU1760984A3 (ru) 1992-09-07
HUT47551A (en) 1989-03-28
IL86959A (en) 1992-12-01
JPH0331709B2 (enExample) 1991-05-08
SU1706388A3 (ru) 1992-01-15
FI883402A7 (fi) 1989-01-21
ATE102928T1 (de) 1994-04-15
FI883402L (fi) 1989-01-21
CN1021046C (zh) 1993-06-02
DE3888415T2 (de) 1994-07-14
EP0300400A1 (en) 1989-01-25

Similar Documents

Publication Publication Date Title
MX12317A (es) Derivados de ester nitrico y procedimiento para suobtencion.
CA2126327A1 (en) Amidino derivatives and their use as nitric oxide synthase inhibitors
NO903438D0 (no) Fremgangsmaate for fremstilling av tiazolderivater.
IL88507A (en) 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
HU900064D0 (en) Process for preparation of new 2-amino pyrimidinone-derivatives
ATE79880T1 (de) Chinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ATE2265T1 (de) Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
PT95854A (pt) Processo para a preparacao de composicoes contendo derivados de pirimidona e analogos, uteis no tratamento da asma e de certas perturbacoes da pele
EP0263506A3 (en) Anticonvulsant composition containing amino acid derivative and use of said amino acid derivative
ES2061579T3 (es) Compuestos cefem y procedimientos para su preparacion.
JPS56110683A (en) Preparation of optical active epoxysuccinate
ZA885358B (en) Uricosuric composition